Fresh analysis indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass far faster than those who halt traditional diet and exercise regimens.
Research printed in a prominent health publication shows that while obese people can lose about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"People buying these medications need to be cognizant of the potential of rapid weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight within about 18 months.
Comparing Approaches
The study, which reviewed dozens of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
The team note that individuals who lose weight through lifestyle changes alone generally have a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
Explaining the Fast Rebound
Doctors believe the way of the drugs is key to understanding the amplified rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication means appetite is uncontrolled, making binge eating far more likely."
A Lifelong Issue?
The NHS suggest the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
Professionals argue that, given the significant potential of weight regain, the therapy should be considered life-long.
This perspective is echoed by drug manufacturers, who state that the findings "emphasize the chronic character of excess weight," akin to managing diseases like high blood pressure.
Patient Testimonies
People who have discontinued the jabs describe a sudden resurgence of appetite.
"It was like a switch activating and you become starving," said one woman.
This difficulty is worsened if users have not adopted lasting lifestyle or habit changes during therapy.
Widespread Interest
Figures show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is more common among women compared to males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, experts stress that while these medications are powerful tools for weight loss, they are not a magic cure and lasting health benefits hinges on integrated lifestyle support.
